1. Home
  2. PRSU vs NEO Comparison

PRSU vs NEO Comparison

Compare PRSU & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pursuit Attractions and Hospitality Inc.

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$45.45

Market Cap

1.1B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$11.46

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSU
NEO
Founded
1926
2001
Country
United States
United States
Employees
2100
N/A
Industry
Business Services
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
PRSU
NEO
Price
$45.45
$11.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$31.67
$13.38
AVG Volume (30 Days)
194.5K
1.2M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.85
$10.63
Revenue Next Year
$4.94
$9.73
P/E Ratio
$3.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.92
$4.72
52 Week High
$45.75
$13.74

Technical Indicators

Market Signals
Indicator
PRSU
NEO
Relative Strength Index (RSI) 63.45 72.21
Support Level $32.34 $7.50
Resistance Level $45.61 $12.60
Average True Range (ATR) 1.18 0.56
MACD -0.07 0.18
Stochastic Oscillator 91.92 96.14

Price Performance

Historical Comparison
PRSU
NEO

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, Iceland and Costa Rica. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: